Ana Monczor

Statistics

Publications

Citations

292

H-Index

Active since

2006

Affiliations

The University of Texas Health Science Center at Houston(Current)

Duke University

Fred Hutch Cancer Center

Beth Israel Deaconess Medical Center

Los Alamos National Laboratory

Ana Monczor is an author at The University of Texas Health Science Center at Houston specializing in antiretroviral therapy, monoclonal antibodies, and open-label placebo.

Publications per year

2006–2022

Publications

Safety and antiviral activity of triple combination broadly neutralizing monoclonal antibody therapy against HIV-1: a phase 1 clinical trial

Boris Jülg, Kathryn E. Stephenson, Kshitij Wagh et al. · Nature Medicine · 2022 · 141 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Safety, pharmacokinetics and antiviral activity of PGT121, a broadly neutralizing monoclonal antibody against HIV-1: a randomized, placebo-controlled, phase 1 clinical trial

Kathryn E. Stephenson, Boris Jülg, Chen Sabrina Tan et al. · Nature Medicine · 2021 · 102 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Higher transactivation activity associated with LTR and Tat elements from HIV-1 BF intersubtype recombinant variants

Gabriela Turk, Mauricio Carobene, Ana Monczor et al. · Retrovirology · 2006 · 25 citations · Full text

Life Sciences, Genetics, Molecular Biology +17

Evaluation of Six Weekly Oral Fecal Microbiota Transplants in People with HIV

Netanya S. Utay, Ana Monczor, Anoma Somasunderam et al. · Pathogens and Immunity · 2020 · 24 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

1–4 of 4